Cipla LtdOTC Pink - Limited Information:CPLFY
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (---)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cipla Ltd | 13.6B | 0.0x | --- |
Dbv Technologies SA | 123.8M | -1.8x | --- |
Assembly Biosciences Inc | 73.2M | -0.9x | --- |
Zevra Therapeutics Inc | 196.3M | -3.5x | --- |
CorMedix Inc | 285.4M | -5.8x | --- |
Incannex Healthcare Inc | 36.5M | -5.8x | --- |
Company Information
Cipla Limited is an India-based company, which is primarily engaged in the business of pharmaceuticals. The Company operates through two segments: Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. The Company's product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, the United States, South Africa, and Rest of the World. The Company has its network of manufacturing, trading and other incidental operations in India and International markets. The Company has approximately 47 manufacturing sites.
Contact Information
- Headquarters
- Mumbai CentralMUMBAI, India 400013
- Phone
- 222-482-6000
- Fax
- 222-482-6120
Executives
- Non-Executive Chairman of the Board
- Yusuf Hamied
- Global Chief Executive Officer, Managing Director, Executive Director
- Umang Vohra
- Non-Executive Vice Chairman of the Board
- M. Hamied
- Global Chief Financial Officer
- Ashish Adukia
- Chief Executive Officer - One India Business
- Achin Gupta
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.6B |
|---|---|
Revenue (TTM) | $278.8M |
Shares Outstanding | 807.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.04 |
Book Value | $0.62 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 48.9 |
Price/Cash Flow (TTM) | 244.3x |
Operating Margin | 22.16% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
